Business Strategy Expansion of Biopharma Product Portfolio with Single-use Assemblies

Source: Press release Ahlam Rais 1 min Reading Time

Related Vendors

Freudenberg Medical has expanded its biopharma product portfolio to include custom single-use assemblies which combine Freudenberg’s expertise in silicone extrusion and molding.

New offerings include, but are not limited to, single-use y-connector manifolds, tubing assemblies, and bottle cap assemblies with multiple inlets/outlets. (Source:  Freudenberg Medical)
New offerings include, but are not limited to, single-use y-connector manifolds, tubing assemblies, and bottle cap assemblies with multiple inlets/outlets.
(Source: Freudenberg Medical)

Freudenberg Medical, a manufacturer of medical and pharmaceutical devices, components and tubing, has expanded its biopharma product portfolio to include custom single-use assemblies which combine Freudenberg’s expertise in silicone extrusion and molding. New offerings include, but are not limited to, single-use y-connector manifolds, tubing assemblies, and bottle cap assemblies with multiple inlets/outlets. Bottlecap assemblies with y-connector tubing are commonly used in lab or cGMP bioprocesses for critical fluid transfer applications.

All assemblies are cleanroom manufactured according to customer specifications. Y-connector overmolds guarantee an unobstructed flow within a critical fluid path and will prevent leaks commonly seen with standard fluid couplings, fittings and connectors. Validated production processes with proven process capabilities will continuously ensure consistent overmolding of y-manifolds on customer-specified tube ends.

Freudenberg’s expanded biopharma solutions complement the existing Pharmafocus Premium line of high purity, platinum-cured silicone tubing and sanitary ends for single-use systems. Freudenberg’s tubing, molded components and systems are used in bioprocessing, biotechnology, lab processes, GMP manufacturing, small batch processes, cell & gene therapy, and the production of mRNA, biosimilars and regenerative proteins.

(ID:50139968)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent